TAKEDA PHARMACEUTICAL COMPANY LIMITED

(4502)
  Report
Delayed Japan Exchange  -  02:00 2022-06-27 am EDT
3776.00 JPY   +1.86%
06:02aResults from Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin Deficiency Published in New England Journal of Medicine
BU
06/24Takeda Pharmaceutical to Absorb Businesses From Unit Nihon Pharmaceutical
MT
06/22Takeda Announces Creation of One Cambridge Campus in Kendall Square to Drive Innovation Efforts
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about TAKEDA PHARMACEUTICAL COMPANY LIMITED
06:02aResults from Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin Deficienc..
BU
06/24Takeda Pharmaceutical to Absorb Businesses From Unit Nihon Pharmaceutical
MT
06/22Takeda Announces Creation of One Cambridge Campus in Kendall Square to Drive Innovation..
BU
06/22Takeda Signs 15-Year Lease with BioMed Realty
CI
06/17MARKETSCREENER'S WORLD PRESS REVIEW : June 17, 2022
06/17Takeda, Nintendo among Japanese firms quietly celebrating weak yen
RE
06/10Takeda's Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Th..
AQ
06/10TAKEDA PHARMACEUTICAL : Notice Concerning Disposal of Treasury Shares under the Long-Term ..
PU
06/09Takeda Pharmaceutical Says Dengue Vaccine Candidate 84% Effective Against Hospitalizati..
MT
06/09Takeda's Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Th..
BU
06/07Takeda Canada applauds Quebec's new Rare Disease Policy
AQ
06/02Asian ADRs Move Higher in Thursday Trading
MT
06/02Takeda Pharmaceutical Company Limited - Notice Concerning Withdrawal of Shelf Registrat..
AQ
06/01Takeda Pharmaceutical to Pass On Marketing Authorization of COVID-19 Vaccine Spikevax i..
MT
06/01Japan Index Posts Moderate Gains as Border Restrictions Ease; Mercari Shares Surge 7%
MT
05/31Takeda and Moderna Announce Plans to Transfer Marketing Authorization for SpikevaxTM CO..
AQ
05/31Takeda Presents Latest Research from Oncology Portfolio and Pipeline at ASCO & EHA
BU
05/31TAKEDA PHARMACEUTICAL : Current Report by Foreign Issuer (Form 6-K)
PU
05/31TAKEDA PHARMACEUTICAL : Current Report by Foreign Issuer (Form 6-K)
PU
05/31Moderna to Receive Marketing Authorization Transfer for COVID-19 Vaccine in Japan From ..
MT
05/31Takeda and Moderna Announce Plans to Transfer Marketing Authorization for Spikevax&trad..
BU
05/31Takeda and Moderna Announce Plans to Transfer Marketing Authorization for Spikevax™..
CI
05/27TAKEDA PHARMACEUTICAL : and Seagen to Highlight ADCETRIS Combination Data
PU
05/26Takeda and Seagen to Highlight ADCETRIS® Combination Data Showing Statistically Signifi..
BU
05/12Japan Index Ends in Red; Toyota Clocks Record-High FY22 Attributable Income but Project..
MT
05/11Takeda Pharmaceutical's FY22 Attributable Profit Falls 39%
MT
05/11GLOBAL MARKETS LIVE : Coinbase, Roblox, Apple, EA, Hasbro...
05/11TRANSCRIPT : Takeda Pharmaceutical Company Limited, Q4 2022 Earnings Call, May 11, 2022
CI
05/11TRANSCRIPT : Takeda Pharmaceutical Company Limited, 2022 Earnings Call, May 11, 2022
CI
05/11Takeda Pharmaceutical Posts Higher Profit, Revenue in Fiscal 2021
MT
05/11Takeda Pharmaceutical Posted Fourth-Quarter Net Loss
DJ
05/11Takeda Delivers Strong FY2021 Results; Continued Growth Momentum Expected in FY2022
BU
05/11Takeda Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended ..
CI
05/11Takeda Pharmaceutical Company Limited Declares Dividend for the Year Ended March 31, 20..
CI
05/11Takeda Pharmaceutical Company Limited Provides Consolidated Earnings Guidance for the F..
CI
04/29OncoSec Medical Names Robert Arch CEO; Shares Rise Early
MT
04/29HilleVax Shares Gain Ground in Trading Debut After Upsized IPO
DJ
04/28CENTOGENE and Takeda Extend Market Access and Expansion Partnership to Advance Patient ..
AQ
04/27Takeda Recognized as 2022 ISPE Facility of the Year Awards Winner in Two Categories
AQ
04/26Takeda Holds Fourth Quarter and Full-Year FY2021 Earnings Call on May 11
AQ
04/26Takeda Recognized as the 2022 ISPE Facility of the Year Awards Winner in Two Categories
BU
04/25TAKEDA PHARMACEUTICAL : Holds Fourth Quarter and Full-Year FY2021 Earnings Call on May 1
PU
04/25HilleVax Sets IPO at 10.3 Million Shares; Sees Pricing at $16-$18
DJ
04/22Takeda Pharmaceutical Says Livtencity Treatment Reduces Hospitalizations in Transplant ..
MT
04/22Takeda Presents New Exploratory Analysis Showing Patients Treated With LIVTENCITY&trade..
BU
04/20Takeda to Manufacture Novavax's COVID-19 Vaccine Following Government Approval and Purc..
MT
04/19Novavax Shares Fall 1% Following Nuvaxovid Approval in Japan
DJ
04/19Takeda's TAKHZYRO (lanadelumab-flyo) Prefilled Syringe Now Available for People With He..
AQ
04/19Finch Therapeutics to Cut 20% of Staff in Restructuring
DJ
04/19CORRECTION : Takeda Pharmaceutical's COVID-19 Vaccine Nuvaxovid Gets Approval in Japan
MT
04/19Takeda Pharmaceutical's COVID-19 Vaccine Nuvaxoid Gets Approval in Japan
MT
04/18Takeda Announces Approval of Nuvaxovid® COVID-19 Vaccine for Primary and Booster Immuni..
BU
04/18Takeda Announces Approval of Nuvaxovid Covid-19 Vaccine for Primary and Booster Immuniz..
CI
04/18Takeda Pharmaceutical's Prefilled Takhzyro Syringe Now Available in US
MT
04/18Takeda's TAKHZYRO® (lanadelumab-flyo) Prefilled Syringe Now Available for People With H..
BU
04/18Takeda’s TAKHZYRO® (lanadelumab-flyo) Prefilled Syringe Now Available for People W..
CI
04/14Takeda Pharmaceutical Closes $797 Million Share Buyback
MT
04/13Takeda Announces Completion of Acquisition of Own Shares
BU
04/13Tranche Update on Takeda Pharmaceutical Company Limited's Equity Buyback Plan announced..
CI
04/12Takeda Says Phase 3 Trial of Takhzyro in Pediatric Hereditary Angioedema Meets Safety, ..
MT
04/12Takeda's TAKHZYRO® (lanadelumab) Open Label Phase 3 Study Met Its Objectives in Childre..
BU
04/12Takeda’s Takhzyro® (Lanadelumab) Open Label Phase 3 Study Met Its Objectives in Ch..
CI
04/12TAKEDA : Pediatric Hereditary Angioedema Study Meets Objectives
DJ
04/12Takeda Pharmaceutical Company Limited 's Equity Buyback announced on October 28, 2021, ..
CI
04/09Exclusive Speaker Interview with Ester Lovsin Barle Ahead of the 6th Annual Highly Pote..
AQ
04/06Evozyne Partners With Takeda Pharmaceutical to Develop Gene Therapies
MT
04/05Takeda and the New York Academy of Sciences Announce 2022 Innovators in Science Award W..
BU
04/04Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting
AQ
04/01Takeda Pharmaceutical Company Limited Announces Executive Changes
CI
04/01Australian Shares Post Small Loss Amid Decline in Business Confidence
MT
04/01Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting
BU
04/01Tranche Update on Takeda Pharmaceutical Company Limited's Equity Buyback Plan announced..
CI
04/01Takeda Pharmaceutical Company Limited acquired A-Digital, Inc.
CI
03/31Hasten Biopharmaceutic Co., Ltd. completed the acquisition of A Portfolio of Five Selec..
CI
03/30Japan Index Comes under Pressure; JCR Pharmaceuticals and Takeda Sign Licensing and All..
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on TAKEDA PHARMACEUTICAL COMPANY LIMITED